Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.55 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.53 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24334938 | 0.85 | FDPS (0.53) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL14828666 | 0.83 | FDPS (0.56) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL29669201 | 0.83 | SLC6A2 (0.57) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL30082869 | 0.83 | FDPS (0.56) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL2096123 | 0.83 | FDPS (0.51) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL290633 | 0.83 | SLC6A2 (0.57) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL12632304 | 0.83 | FDPS (0.56) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL25756815 | 0.83 | FDPS (0.51) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL12894954 | 0.83 | SLC6A2 (0.57) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 | |
| SCHEMBL27739281 | 0.83 | FDPS (0.51) | FDPSCHRNB2CHRNA4CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116655447-A | Application of pyridine ligand modified ruthenium-based catalyst in acetylene hydrochlorination | 南开大学 | 2023-08-29 | — | — | CN | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | HENKEL AG & CO. KGAA (DE) | 2021-02-16 | — | — | US | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| EP-3350296-A1 | PERFUME COMPOSITION COMPRISING AN ODOR MODULATOR COMPOUND, AMINO ALCOHOL AND ODORIFEROUS ALDEHYDE AND/OR ODORIFEROUS KETONE FOR INCREASING AND PROLONGING ODOR INTENSITY | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-3349861-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-3350295-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND 1-AZA-3,7-DIOXABICYCLO[3.3.0]OCTANE COMPOUNDS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-3350297-A1 | TRANSPARENT LIQUIDS, IN PARTICULAR FABRIC TREATMENT AGENTS, CONTAINING PERFUME AND MICROCAPSULES WITH AN ODOR MODULATOR COMPOUND | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| US-20180201883-A1 | TRANSPARENT LIQUIDS, IN PARTICULAR FABRIC TREATMENT AGENTS, COMPRISING PERFUME AND MICROCAPSULES WITH AN ODOR MODULATOR COMPOUND | HENKEL AG & CO. KGAA (DE) | 2018-07-19 | — | — | US | claimed |
| WO-2017046055-A1 | PERFUME COMPOSITIONS COMPRISING MICROCAPSULES, FRAGRANCE MODULATOR COMPOUNDS AND FRAGRANCE RAW MATERIAL FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2017-03-23 | — | — | WO | claimed |
| EP-2224807-B1 | METHODS FOR STEREOSELECTIVE REDUCTION | INFINITY PHARMACEUTICALS INC (US) | 2016-11-09 | — | — | EP | claimed |
| US-9238672-B2 | Methods for stereoselective reduction | INFINITY PHARMACEUTICALS, INC. (US) | 2016-01-19 | — | — | US | claimed |
| US-20140357868-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | INFINITY PHARMACEUTICALS, INC. (US) | 2014-12-04 | — | — | US | claimed |
| CN-101917853-B | Method for stereoselective reduction | INFINITY PHARMACEUTICALS INC | 2014-03-19 | — | — | CN | claimed |
| US-20110009442-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | ROYALTY SECURITY, LLC | 2011-01-13 | — | — | US | claimed |
| CN-101917853-A | Method for stereoselective reduction | INFINITY PHARMACEUTICALS INC | 2010-12-15 | — | — | CN | claimed |
| EP-2224807-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | Infinity Pharmaceuticals, Inc. (US) | 2010-09-08 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2009086451-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | INFINITY PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | WO | claimed |
| US-6906069-B1 | Diagnosis indicator; anticholesterol agents; antilipemic agents; antidiabtic agents | AMGEN INC. (US) | 2005-06-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009442-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | HSD17B7, CYP17A1, HSD11B1 | FDPS 155/4885CHRNB2 1514/4885CHRNA4 1465/4885 |
| US-20140357868-A1 | METHODS FOR STEREOSELECTIVE REDUCTION | HSD17B7, CYP17A1, HSD11B1 | FDPS 155/4885CHRNB2 1514/4885CHRNA4 1465/4885 |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | NEFM, TRPA1, ALOX5 | FDPS 232/4885CHRNB2 1473/4885CHRNA4 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.